Category Specific RSS

News

Food Revolution pivots into hand sanitiser production, shares surge 49%

With a bottling production plant already in operation, food processing company Food Revolution Group (ASX: FOD) has received enough interest in hand sanitiser to quickly commission a new bottling line to fill a global supply gap in the sanitary product. 

Whilst the company does not have a line of sanitary products, its Melbourne plant has the capacity to produce and bottle numerous products including gels, powders and oils. Commissioning of the new line is already underway as customers in China seek to contain the coronavirus outbreak. 

Within its bottling line, Food Revolution has the capacity to fill bottles up to 4 litres with the machine confirmed as suitable for alcohol-based hand sanitiser. It will be the same multi-purpose machine which the company also uses for bottling canola oil. 

The new line of sanitary products will be produced by Food Revolution under their new ‘Sanicare’ brand, with production expected to commence before the end of February and be distributed by Careline Australia, FOD’s distribution partner. 

“The versatility of FOD’s upgraded plant with clean room and bottling capacity to meet the substantial demands of the Chinese market is evidenced by these developments and vindicates the company’s decision to invest in the new clean room factory to provide constant supply of high quality Australian products to the Chinese market,” said Food Revolution Chairman, Dr Norman Li. 

The majority of the new Sanicare products will be sent directly to China where there is unprecedented demand for hand sanitiser but Food Revolution will look to continue sanitiser production complementary to their established food products. 

To facilitate the additional production, two more machines have been built in China for Food Revolution’s new clean room factory which will enable powder sachet packaging and gel sachet packaging. 

Following news of the new Sanicare production line, shares in Food Revolution rocketed to an intra-day high of $0.085, a rise of 49% on the previous day’s close of $0.057. 

Alfred Chan

Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.

Recent Posts

AML3D announces stronger FY26, with positive EBITDA reported in the second half

Adelaide-based metal printing group books record $12.5 million revenue and a record $78 million sales…

3 days ago

Refurbished tech gives Harris Technology a second life

Harris Technology has found a higher-margin growth engine in an unlikely place: the market for…

4 days ago

Imagion Biosystems Advances MagSense® Phase 2 Trial

Imagion Biosystems (ASX: IBX) is moving its MagSense® HER2 Imaging Agent Phase 1b/2 clinical trial…

1 week ago

Acrux-developed Menopause Hormone Therapy to enter Australian market

Acrux (ASX:ACR) is set to bring its transdermal Estradiol spray Lenzetto® to the Australian market…

3 months ago

Evion Expands Critical Minerals Push with Nevada Fluorspar Option

The race to secure Western-aligned critical minerals supply chains is accelerating as governments and industry…

4 months ago

Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone

Green360 Technologies (ASX:GT3) has taken a major step forward in the commercialisation of its low-carbon…

4 months ago